Clinical Trial Update: Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 2]

View source ↗

Summary

Phase 2 trial update showing results for ofatumumab in high-risk chronic lymphocytic leukemia and small lymphocytic lymphoma, with trial results posted after st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19